INIBIC-EC-Artigos: Envíos recientes
Mostrando ítems 1-5 de 31
-
Safety and efficacy of tirofiban in acute ischemic stroke due to tandem lesions undergoing mechanical thrombectomy: A multicenter randomized clinical trial (ATILA) protocol
(Sage, 2022-12-28)[Abstract] Background: In-stent thrombosis after mechanical thrombectomy (MT) worsen outcomes in acute ischemic stroke (AIS) due to tandem lesions (TL). Although an optimal antiplatelet therapy is needed, the best approach ... -
Safety and efficacy of ApTOLL in patients with ischemic stroke undergoing endovascular treatment: a phase 1/2 randomized clinical trial
(American Medical Association, 2023-06-20)[Abstract] Importance: ApTOLL is a TLR4 antagonist with proven preclinical neuroprotective effect and a safe profile in healthy volunteers. Objective: To assess the safety and efficacy of ApTOLL in combination with ... -
Pre-existing cerebral small vessel disease limits early recovery in patients with acute lacunar infarct
(Elsevier, 2019-11)[Abstract] Background and purpose: To assess whether neuroimaging markers of chronic cerebral small vessel disease (cSVDm) influence early recovery after acute ischemic stroke (AIS). Methods: Retrospective analysis ... -
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain
(Sage, 2020-06-11)[Abstract] Background and purpose: Spain has been one of the countries heavily stricken by COVID-19. But this epidemic has not affected all regions equally. We analyzed the impact of the COVID-19 pandemic on hospital ... -
Blood biomarker panels for the early prediction of stroke‐associated complications
(American Heart Association, 2021-02-26)[Abstract] Background. Acute decompensated heart failure (ADHF) and respiratory tract infections (RTIs) are potentially life‐threatening complications in patients experiencing stroke during hospitalization. We aimed to ...